149 related articles for article (PubMed ID: 9815273)
1. Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus.
Tebbey PW; Hagen M; Hancock GE
J Exp Med; 1998 Nov; 188(10):1967-72. PubMed ID: 9815273
[TBL] [Abstract][Full Text] [Related]
2. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.
Srikiatkhachorn A; Braciale TJ
J Exp Med; 1997 Aug; 186(3):421-32. PubMed ID: 9236194
[TBL] [Abstract][Full Text] [Related]
3. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease.
Spender LC; Hussell T; Openshaw PJ
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1751-8. PubMed ID: 9680139
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein.
Johnson TR; Rothenberg ME; Graham BS
J Leukoc Biol; 2008 Sep; 84(3):748-59. PubMed ID: 18519743
[TBL] [Abstract][Full Text] [Related]
5. CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease.
Olson MR; Varga SM
J Immunol; 2007 Oct; 179(8):5415-24. PubMed ID: 17911628
[TBL] [Abstract][Full Text] [Related]
6. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein.
Bembridge GP; Garcia-Beato R; López JA; Melero JA; Taylor G
J Immunol; 1998 Sep; 161(5):2473-80. PubMed ID: 9725246
[TBL] [Abstract][Full Text] [Related]
7. Immune responses to the nonglycosylated ectodomain of respiratory syncytial virus attachment glycoprotein mediate pulmonary eosinophilia in inbred strains of mice with different MHC haplotypes.
Hancock GE; Tebbey PW; Scheuer CA; Pryharski KS; Heers KM; LaPierre NA
J Med Virol; 2003 Jun; 70(2):301-8. PubMed ID: 12696122
[TBL] [Abstract][Full Text] [Related]
8. IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions.
Hussell T; Openshaw PJ
J Immunol; 2000 Dec; 165(12):7109-15. PubMed ID: 11120841
[TBL] [Abstract][Full Text] [Related]
9. Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus.
Castilow EM; Olson MR; Meyerholz DK; Varga SM
J Virol; 2008 Mar; 82(5):2196-207. PubMed ID: 18094193
[TBL] [Abstract][Full Text] [Related]
10. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection.
Hussell T; Georgiou A; Sparer TE; Matthews S; Pala P; Openshaw PJ
J Immunol; 1998 Dec; 161(11):6215-22. PubMed ID: 9834108
[TBL] [Abstract][Full Text] [Related]
11. Fas ligand is required for the development of respiratory syncytial virus vaccine-enhanced disease.
Olson MR; Varga SM
J Immunol; 2009 Mar; 182(5):3024-31. PubMed ID: 19234198
[TBL] [Abstract][Full Text] [Related]
12. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
[TBL] [Abstract][Full Text] [Related]
13. Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV.
Johnson TR; Varga SM; Braciale TJ; Graham BS
J Virol; 2004 Aug; 78(16):8753-60. PubMed ID: 15280483
[TBL] [Abstract][Full Text] [Related]
14. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
[TBL] [Abstract][Full Text] [Related]
15. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
Cyr SL; Jones T; Stoica-Popescu I; Brewer A; Chabot S; Lussier M; Burt D; Ward BJ
Vaccine; 2007 Jul; 25(29):5378-89. PubMed ID: 17561317
[TBL] [Abstract][Full Text] [Related]
16. Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragment.
Plotnicky-Gilquin H; Cyblat-Chanal D; Aubry JP; Champion T; Beck A; Nguyen T; Bonnefoy JY; Corvaïa N
J Virol; 2002 Oct; 76(20):10203-10. PubMed ID: 12239295
[TBL] [Abstract][Full Text] [Related]
17. CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection.
Hussell T; Baldwin CJ; O'Garra A; Openshaw PJ
Eur J Immunol; 1997 Dec; 27(12):3341-9. PubMed ID: 9464822
[TBL] [Abstract][Full Text] [Related]
18. Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein.
Elliott MB; Pryharski KS; Yu Q; Boutilier LA; Campeol N; Melville K; Laughlin TS; Gupta CK; Lerch RA; Randolph VB; LaPierre NA; Dack KM; Hancock GE
J Virol; 2004 Aug; 78(16):8446-54. PubMed ID: 15280453
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus infection of gene gun vaccinated mice induces Th2-driven pulmonary eosinophilia even in the absence of sensitisation to the fusion (F) or attachment (G) protein.
Bembridge GP; Rodriguez N; Garcia-Beato R; Nicolson C; Melero JA; Taylor G
Vaccine; 2000 Dec; 19(9-10):1038-46. PubMed ID: 11137237
[TBL] [Abstract][Full Text] [Related]
20. Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P.
Haynes LM; Jones LP; Barskey A; Anderson LJ; Tripp RA
J Virol; 2003 Sep; 77(18):9831-44. PubMed ID: 12941892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
